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Switchable selectivity within a series of boronate esters for dynamic 
covalent exchange in nonaqueous solvents 
The reversible condensation–hydrolysis reactions of boronic acids have proven 
to be a highly useful class of thermodynamically controlled dynamic covalent 
process, enabling the construction of sugar sensors, stimuli-responsive materials, 
and complex covalent architectures. Yet, the common diol or diphenol coupling 
partners tend to produce relatively unstable condensation products, exhibit 
oxidative sensitivity, or offer limited options for expanding structural diversity. 
To address these drawbacks, we explore a series of coupling partners including 
non-diol salicylate and salicylamide derivatives, in combination with two boronic 
acids. In nonaqueous solvents, the condensation–hydrolysis equilibria are 
sensitive to the nature and concentration of Lewis bases, with equilibrium 
constants that can be tuned across at least five orders of magnitude. 
Furthermore, differential responses to base concentration can be exploited to 
create a switchable dynamic covalent system in which a boronic acid can be 
cycled between expressing each of two condensation products with high fidelity, 
in response to a simple chemical stimulus. 
Keywords: dynamic covalent chemistry; adaptive systems; constitutional 
dynamic chemistry; salicylates; catechols; boronate esters; boronic acids; boronic 
esters 
Introduction 
The esters and anhydrides formed by boronic acids have received considerable attention 
as dynamic covalent functional groups.(1–2) They have been exploited, for example, to 
construct complex molecular architectures,(3) or extended crystalline organic 
frameworks;(4) to detect sugars,(5) or to actuate stimuli-responsive materials and drug-
delivery devices.(6) The majority of these studies focus on aqueous systems, and 
particularly the reactions between boronic acids and aliphatic 1,2- or 1,3-dihydroxy 
motifs on saccharides or glycosylated biomolecules.(7) Although stabilized by chelate 
cooperativity, the resulting cyclic boronate esters tend to be labile, and display only 
moderate stabilities that are pH dependent.(7–8) Exquisite cooperativity effects in a 
handful of specific molecular architectures can lead to high stability,(3) while 
anhydrous aprotic solvents can maintain boronic ester stability, but typically then 
requiring harsh reaction conditions (e.g. solvothermal approaches) to achieve reversible 
covalent exchange.(3, 9) 
Considerable efforts have been devoted to increasing boronate ester stability 
through modification of the boron functional group,(10) or by introducing stabilizing 
intramolecular interactions.(11) Yet these systems are synthetically demanding and 
therefore remain relatively specialized. Despite significant early work on the reactions 
of boric acid, and sporadic reports spread over several decades since then, far less 
attention has been given to moving away from the common dihydroxy coupling 
partners. Furthermore, the challenges associated with understanding the multiple 
interconnected equilibria and system-dependent mechanistic details, have also 
encouraged a focus on phenomenology at the expense of detailed characterization at the 
molecular level, and most systematic studies have been carried out in aqueous 
systems.(7–8, 12) Attracted by the potential for orthogonality to common biomolecular 
functional groups and established bioorthogonal chemistries, recently Hall and co-
workers have developed conformationally preorganized aliphatic diols that rapidly form 
stable boronate esters in water with an optimized boronic acid ligation partner,(13) 
while Anslyn and James have developed a three-component boronate ester coupling 
strategy using 2-formylphenylboronic acid to link aromatic-1,2-diols (catechols) with 
hydroxylamines.(14) Meanwhile, several groups have exploited boronate complexes 
with salicylhydroxamic acid derivatives for pH-responsive gelation, bioseparation, drug 
delivery, and bioconjugation applications.(15) These advances suggest significant 
potential for discovering boronic acid coupling partners with superior characteristics for 
exploiting the reversibility of boronate ester formation in nonaqueous dynamic covalent 
applications. 
It has long been recognized that catechols commonly exhibit higher boronate 
ester formation constants than their aliphatic analogues.(16) Despite their successful 
application for the construction of covalent organic architectures and frameworks,(3–4) 
and stimuli-responsive polymers or soft nanomaterials,(6) these derivatives are 
challenging to adopt more generally, on account of their facile, irreversible aerobic 
oxidation to form quinones,(17) and a lack of synthetically amenable routes for 
derivatization. As part of our wider efforts to exploit dynamic covalent reactivity for 
surface-engineering of monolayer-stabilized nanoparticles,(18) we have studied 
thermodynamically controlled boronate ester formation and exchange between 
catechols and nanoparticle-bound boronic acids, which we subsequently applied to 
direct reversible assembly and disassembly of covalently linked nanoparticle 
aggregates.(18b) The most reproducible results were achieved using relatively high 
concentrations of tertiary amine Lewis bases in organic solvents (e.g. 900 mM N-
methylmorpholine in methanol). Under these highly basic conditions, catechol oxidation 
is relatively rapid, while the structural scope of catechols that can be readily accessed 
for nanoparticle functionalization is limited. These issues have since led us to 
investigate alternative coupling partners for boronic acids, seeking higher boronate ester 
formation constants at lower concentrations of base, improved stability to aerobic 
oxidation, and structures which might be more amenable to functionalisation. We report 
here a comparative study of four coupling partners, their reversible covalent reactions 
with two model boronic acids (Scheme 1), and quantitative assessment of boronate ester 
formation constants at various concentrations of Lewis base. This investigation has 
allowed us to design a switchable dynamic covalent system whereby a boronic acid 
cycles between selecting each of two coupling partners in response to a simple chemical 
stimulus. 
Results and Discussion 
Boronic acids 1 and 2 (Scheme 1 and Chart S1) were designed as representative 
electron rich (1) and electron poor (2) small-molecule models of functionalized 
phenylboronic acids such as those we have previously incorporated in the monolayer of 
colloidal nanoparticles.(18b) As coupling partners, 4-fluorocatechol A provides a direct 
comparison with our nanoparticle-bound work, while the more acidic nitro-substituted 
analogue B probes the effect of catechol pKa. Motivated by the drawbacks of catechol 
coupling partners (vide supra), and inspired by the recent reports using 
salicylhydroxamic acids in aqueous systems,(15) as well as earlier studies on esters of 
boric acid (also in water),(19) we decided to compare the catechols with salicylic acid 
and salicylamide scaffolds, C and D respectively. These derivatives were chosen for 
their resistance to aerobic oxidation, ease of preparation from readily available 
precursors, and routes to structural elaboration. 
 
Scheme 1. Molecular structures of model electron rich (1) and electron poor (2) 
phenylboronic acids; catechol (A, B), salicylic acid (C) and salicylamide (D) coupling 
partners. See Chart S1 for the structures of all boronate ester complexes studied. 
 
Boronate ester formation was investigated using 19F and 1H NMR spectroscopy 
in CD3OD for a 1:1 stoichiometric ratio of boronic acid and coupling partner, each at ca. 
5 mM. The complexes and their constituent components were observed to be in slow 
exchange on the NMR timescale, so that signals corresponding to each species could be 
independently identified (Figures 1 and S1–S7), and their concentrations determined by 
signal deconvolution relative to an internal standard. Electrospray mass spectrometry 
(Figures S21–S24) provided corroborating evidence that the complexes observed by 
NMR correspond to the boronate ester structures described in Chart S1, Figures 1 and 2.  
On mixing boronic acid 1 with 4-fluorocatechol A, a very small shift ( < 0.01 
ppm) in the 19F NMR signal for the catechol component ( = –124.4 ppm, Figure 1a and 
S1) was observed, perhaps indicating a weak, reversible interaction between the Lewis 
acidic boron and Lewis basic catechol, but without formation of a boronate ester. On 
adding a tertiary amine base such as N-methylmorpholine, a new signal was observed in 
the 19F NMR spectrum at = –126.8 ppm, which was assigned to the boronate ester 1A, 
stabilized by coordination of the nitrogen base at boron. In-line with our previous 
studies on nanoparticles,(18b) the concentration of boronate ester was observed to 
increase with increasing concentration of base (Figure 1c, half-filled circles), reaching a 
maximum at around 100 mM N-methylmorpholine (corresponding to ca. 20 molar 
equivalents with respect to boronic acid and catechol). 
 
Figure 1. Characterization of boronate ester formation with catechol A in response to 
addition of N-methylmorpholine (NMM) by 19F{1H} NMR (CD3OD, 470.1 MHz, 298 
K). (a) Spectra (top to bottom) of: A + 500 mM NMM; A + 1 (no NMM); A + 1 + 500 
mM NMM. (b) Spectra (top to bottom) of: A + 500 mM NMM; 2 + 500 mM NMM; A 
+ 2 (no NMM); A + 2 + 500 mM NMM. Open symbols: uncomplexed components; 
filled/patterned symbols: boronate ester species. (c) Variation of mole fraction of 
boronate ester with increasing concentration of NMM for 1A (half-filled circles) and 2A 
(filled circles). Initial concentrations: [A]0  [1]0 or [2]0  5 mM. See Figures S1 and S4 
for NMR spectra showing a wider chemical shift range for [NMM] = 5, 50, 500 mM; 
see Figures S13a and S14a for full NMM titration data. 
 
The requirement to introduce such high concentrations of base in order to 
maximise boronate ester formation is generally undesirable: the rate of aerobic catechol 
oxidation to quinones (vide supra) is increased under such conditions, and other 
unforeseen side reactions or interactions may arise when working with more complex 
systems. Boronic acid 2 was therefore prepared to investigate whether electron-
withdrawing substituents on the aromatic ring could increase the stabilities of the 
corresponding boronate esters, thus lowering the concentration of Lewis base required 
in order to achieve maximum ester formation. The fluorine substituent also provides a 
spectroscopic probe for boronate ester formation, without requiring fluorine-labelled 
coupling partners. Titrating each boronic acid with N-methylmorpholine and fitting the 
observed chemical shift changes to a 1:1 binding isotherm gave an estimate of the 
equilibrium constant for the acid–base interaction (KaNMM, Figure S8), confirming the 
significantly greater Lewis acidity of 2 (Ka
NMM = 130 M–1) compared to 1 (Ka
NMM = 36 
M–1). Gratifyingly, on titrating N-methylmorpholine into a 1:1 solution of 2 and 
catechol A (ca. 5 mM), formation of boronate ester 2A approached a maximum value 
after only around 20 mM base (ca. 4 molar equivalents with respect to boronic acid and 
catechol, Figure 1c, filled circles), a significant reduction on the value of 100 mM 
required to reach maximal formation of 1A. 
Turning to alternative, non-catechol, coupling partners, we first investigated the 
response of C and D alone to increasing concentrations of N-methylmorpholine. The 
fluorine label in each of A, C and D gives rise to a single 19F NMR signal. Whereas no 
change in chemical shift value was observed on introducing up to 500 mM N-
methylmorpholine to a solution of A (5 mM, CD3OD, Figure S10), the resonances for 
both C and D were shifted upfield on introducing base (Figure 2a, b). The significantly 
steeper response to base concentration observed for C reflects the acidity of the 
carboxylic acid compared to the most acidic site in D (presumably the phenolic proton). 
Fitting to 1:1 binding isotherms gave estimates of equilibrium constants for the 
deprotonation of each compound by N-methylmorpholine (Ka
NMM, Figure S11).(20) It 
should be noted that the chemical shift change for C continues to rise marginally at high 
base concentrations, perhaps indicative of a second deprotonation equilibrium involving 
the phenolic proton. 
 Figure 2. Response of salicylic acid (C) and salicylamide (D) coupling partners to 
concentration of Lewis base. (a, b) Chemical shift change as a function of concentration 
of N-methylmorpholine (NMM) for (a) C and (b) D. (c) Variation of mole fraction of 
boronate ester with increasing concentration of NMM for 1C (half-filled blue circles) 
and 2C (filled blue circles). (d) Variation of mole fraction of boronate ester with 
increasing concentration of NMM for 1D (half-filled green circles) and 2D (filled green 
circles). Initial concentrations of all boronic acids and coupling partners ca. 5 mM. See 
Figures S2, S3, S6, S7 for representative NMR spectra, and Figures S13, S14 for full 
NMM titration data. 
 
The increased acidities of C and D compared to catechol A are reflected in the 
formation of boronate complexes with these coupling partners. In the absence of base, a 
noticeable downfield shift ( = 0.18 ppm) was observed for the 19F resonance of C on 
introducing boronic acid 1 at a 1:1 stoichiometric ratio, again indicative of a weak 
association in fast exchange. Titrating this mixture with N-methylmorpholine gave rise 
to a new resonance for boronate ester 1C, once more in slow exchange on the NMR 
timescale with the individual components (Figure S2). In contrast to 1A, the 
concentration of boronate ester reached a maximum value after adding only 15 mM N-
methylmorpholine (ca. 3 molar equivalents, Figure 2c, half-filled circles). Significantly, 
combining coupling partner C with the more acidic boronic acid 2, a small amount of 
boronate ester was observed even in the absence of N-methylmorpholine (Figure S6), 
and the saturation concentration of boronate ester 2C was reached after only 1 molar 
equivalent of base was added ( 5 mM, Figure 2c, filled circles). Requiring only a 
stoichiometric amount of base to achieve maximum ester formation – with a coupling 
partner that does not undergo oxidative side reactions – represents a significant 
advantage over the original system 1A, which required greater than 20 molar 
equivalents Lewis base ( 100 mM) under the same conditions. 
Salicylamide D exhibited a significantly lower tendency to form boronate esters, 
requiring > 300 mM (1D) and > 50 mM (2D) base to approach maximum ester 
concentrations, respectively (Figure 2d). When combining D with 1 or 2, a low-intensity 
signal in slow exchange with the isolated components was observed in the absence of 
base (Figure S3 and S7). However, on introducing increasing quantities of N-
methylmorpholine, this signal decreased in intensity, concomitant with the growth of a 
second new signal, also in slow exchange with the isolated components. Eventually, 
only the second signal, which could be assigned to the expected boronate complex (1D / 
2D), was observed. We were unable to unambiguously identify the structure of the 
initially formed complex, and so considered the combined concentration of both species 
as reflecting total boronate complex formed at each stage (see Supporting Information). 
Although the lower acidity of D compared to C might account for the different 
behaviours exhibited by these two salicylate derivatives, comparison with catechol A 
clearly reveals that acidity alone does not explain the difference in boronate ester 
stability between these structurally dissimilar coupling partners. Despite being 
considerably less acidic than D, catechol A requires similar concentrations of N-
methylmorpholine to reach maximum ester formation, and furthermore, the 
concentrations of esters observed suggest that 1A and 2A are significantly more stable 
than their salicylamide counterparts 1D and 2D. 
To provide a quantitative comparison of stabilities across a representative range 
of conditions, apparent formation constants (Kapp) were calculated from the equilibrium 
concentrations of all species as measured by NMR spectroscopy for each boronate ester 
at 0, 5, 50, and 500 mM N-methylmorpholine in methanol (Figure 3 and Table S1). In 
agreement with our initial observations, the more electron-deficient boronic acid 2 tends 
to form more stable boronate ester complexes than 1 with all partners. For the less 
acidic coupling partners A, B and D, the highest boronate ester stabilities are observed 
at the highest concentration of base employed (500 mM). Under these conditions the 
formation constants for catechol derivatives (Kapp(1A) = 4000 M
–1; Kapp(2A) = 9700 M
–
1; Kapp(2B) = 46000 M
–1) are significantly higher – by approximately an order of 
magnitude – than their salicylamide counterparts (Kapp(1D) = 470 M–1; Kapp(2D) = 690 
M–1).(21) This trend is also maintained for the lower stabilities observed at lower 
concentrations of base, and can be ascribed to the different structures of boronate ester 
complexes formed by A, B and D. Whereas formation of 6-membered cyclic complexes 
from D involves an entropic penalty, catechols are pre-organized for formation of cyclic 
structures, with minimal entropy loss.(16b) Perhaps equally significant, in both cases, 
condensation with a boronic acid requires disrupting intramolecular hydrogen bonding 
and intermolecular solvent interactions, which would be expected to be more significant 
for the primary amide and acidic phenol(ate) functionalities in D, compared to the 
poorly acidic catechol functionality of A.(22) 
 
Figure 3. Apparent formation constants (Kapp) for boronate ester complexes 1A, 1C, 
1D, 2A, 2B, 2C, 2D, measured in CD3OD with varying concentration of N-
methylmorpholine (NMM) and initial concentrations of all boronic acids and coupling 
partners ca. 5 mM. Values expressed as mean  1 standard deviation of three 
independent replicates. For corresponding NMR spectra, see Figures S1–S7. (*) 
Estimated minimum value for 2C at 5 mM NMM (Kapp > 2.2  106 M–1). (†) Value for 
2C at 50 mM NMM determined by a competition experiment. See Supporting 
Information for details. 
 
The influence of Lewis base concentration and boronic acid acidity on boronate 
complex stabilities can be understood by reference to the minimal scheme of coupled 
equilibria (Scheme 2a) that is commonly used to describe the interaction between a 
generic boronic acid (Ba) and diol coupling partner (P).(7–8, 12, 16a) Coordination of a 
Lewis base changes the hybridisation at boron from sp2 to sp3. Particularly for 
complexes with 1,2-diols – which form a 5-membered chelate – this results in a 
significant relief of ring strain in the ester species, such that these are considerably more 
acidic than the corresponding boronic acids Ka(BaP) >> Ka(Ba), and hence K(Ba–P) >> 
K(Ba0P). The overall result is that the proportion of ester observed (i.e. total 
concentration of complexed species, as described by the measured apparent formation 
constant Kapp) increases on increasing base concentration, and the dominant ester 
species is the tetrahedral form Ba–P. Electron poor phenylboronic acids are better able 
to stabilize the resulting negative charge on boron in the tetrahedral ester complex, but 
also stabilize the uncomplexed tetrahedral form Ba–, so that the effect of boronic acid 
pKa on the observed ester formation equilibrium depends on both partners in question, 
as well as the concentration of base.(23) At lower concentrations of Lewis base, the 
stabilizing effect of increasing acidity at boron is more significant. This is reflected in 
the relative values of the formation constants for complexes of 2 compared to 1: 
Kapp(2A) / Kapp(1A) = 5.6 at low base concentration ([NMM] = 5 mM), but only 2.4 at 
high base concentration ([NMM] = 500 mM); Kapp(2D) / Kapp(1D) = 6.0 at [NMM] = 5 
mM, but only 1.5 at [NMM] = 500 mM. 
 
Scheme 2. (a) Simplified general scheme of coupled equilibria describing the 
interactions between a generic boronic acid (Ba) and a ‘non-acidic’ coupling partner P 
(i.e. Ka(P) << Ka(Ba)), in the presence of a generic Lewis base (Lb). (b) Expanded 
scheme of coupled equilibria describing the interactions between a generic boronic acid 
(Ba) and an ‘acidic’ coupling partner P (i.e. Ka(P) >> Ka(Ba)), in the presence of a 
generic Lewis base (Lb). As the acid–base equilibria are all in fast exchange on the 
NMR timescale, apparent association constants observed experimentally correspond to 
the total concentrations of complexed and uncomplexed species: Kapp = [BaP]total / 
([Ba]total[P]total). 
 
Salicylic acid coupling partner C exhibits quite different behaviour. As already 
noted, maximum formation of boronate ester 1C is achieved around 15 mM N-
methylmorpholine, which is reflected in the single point formation constants measured 
at base concentrations of 5 mM (Kapp(1C) = 2600 M
–1) and 50 mM (Kapp(1C) = 4500 M
–
1). Interestingly, these values do not differ greatly from the maximum equilibrium 
constant observed for 1A, formed from the highly pre-organized catechol partner 
(Kapp(1A) = 4000 M
–1, at [NMM] = 500 mM). Even more intriguing, was the 
observation of a small but significant decrease in stability of complex 1C at very high 
Lewis base concentrations (Kapp(1C) = 2500 M
–1, at [NMM] = 500 mM). In 
combination with boronic acid 2, as suggested by our preliminary observations, a small, 
but appreciable, formation constant can be calculated in the absence of base (Kapp(2C) = 
16 M–1). Meanwhile on adding only 5 mM N-methylmorpholine, formation of complex 
2C is almost entirely quantitative. Neither diluting the system 10-fold, while 
maintaining a stoichiometric quantity of base ([2]0  [C]0  [NMM] = 0.5 mM), nor 
performing a competition experiment in the presence of catechol A was able to disrupt 
complex 2C sufficiently to allow measurable concentrations of uncomplexed species, so 
that only a lower bound for the value of Kapp(2C) can be estimated by NMR analysis (> 
2.2  106 M–1, at [NMM] = 5 mM; see Supporting Information Section 2.1 for further 
details). As observed for 1C, on further increasing the concentration of Lewis base, the 
stability of boronate ester 2C decreased, this time quite significantly, so that the 
formation constant at 500 mM is at least two orders of magnitude less than the 
maximum value (Kapp(2C) = 5000 M
–1 at [NMM] = 500 mM). 
The observation that high concentrations of base shift the equilibria for boronate 
complex formation with salicylates back towards the dissociated components can be 
explained by a more detailed consideration of the thermodynamic scheme and relative 
acidities of both interacting species.(7, 12c, 12d, 24) Coupling partners A (no 
measurable interaction), B (Ka
NMM = 9.8 M–1) and D (Ka
NMM = 8.9 M–1) can be 
considered to be less acidic than boronic acids 1 (Ka
NMM = 36 M–1) or 2 (Ka
NMM = 130 
M–1), so that the thermodynamic system is well described by Scheme 2a: the most 
favourable interaction for the Lewis base is at boron; the next most acidic site being the 
phenol on A, B or D. On the other hand carboxylic acid C (Ka
NMM = 2900 M–1) is 
significantly more acidic than either of the boronic acids. In this system, the first 
deprotonation involves the coupling partner itself; the second most acidic site being at 
boron (Scheme 2b). Whichever scheme is applicable, boronate ester formation is most 
favourable when there is no change in overall charge between the dissociated 
components and complexed species.(24) Under the conditions employed here, which 
strongly favour negatively charged tetrahedral boron complexes, formation should be 
maximized midway between the first and second deprotonations of the isolated 
components.(24) Consequently, ester formation increases with the concentration of 
Lewis base initially, but as the pKa for the second most acidic site on the isolated 
components is approached, boronate complexes are destabilized and the equilibria shift 
to favour higher concentrations of the dissociated species. For A, B and D this regime is 
not encountered within the range of base concentrations employed here. For highly 
acidic C, however, complex destabilization occurs at relatively low concentrations of 
Lewis base. This accounts for the observation that (a) boronate complexes with salicylic 
acid C are most stable at intermediate concentrations of base; and (b) the optimum base 
concentration is lower for complex 2C – formed with the more acidic boronic acid – 
compared to complex 1C.(25) 
The dissimilar absolute stabilities of salicylate and catechol boronate complexes, 
and their distinctive responses to varying concentration of Lewis base, led us to 
envisage a responsive system where the preferred coupling partner for a boronic acid 
could be reversibly switched by a simple chemical stimulus. In-line with the measured 
formation constants (Figure 3, Table S1), combining boronic acid 2, with equimolar 
quantities of 4-fluorocatechol A, 4-fluorosalicylic acid C, and N-methylmorpholine, 
gave a product mixture consisting almost exclusively of complex 2C (2A:2C 6:94). On 
increasing the concentration of N-methylmorpholine, the system responded to produce 
complex 2A at the expense of 2C. As expected from the respective formation constants, 
the equilibrium composition could be switched to favour complex 2A at a ratio of ca. 
2:1 (2A:2C) in the presence of 920 mM N-methylmorpholine ( 190 equivalents, Figure 
S16a, Table S2). 
An improved response – in terms of both switching fidelity and reduced 
concentration of the Lewis base stimulus required – was achieved by changing to the 
stronger Lewis base N,N-diisopropylethylamine (DIPEA).(26) Boronate ester stabilities 
were found to be more sensitive to changes in Lewis base concentration using the 
stronger Lewis base (compare Figures S14, S15). Formation of ester 2A was maximised 
in the presence of ca. 1.8 molar equivalents N,N-diisopropylethylamine (Figure S15a, 
compared to ca. 4 molar equivalents of NMM). With acidic coupling partner C, 
virtually quantitative formation of boronate ester 2C was again observed with only 1 
molar equivalent N,N-diisopropylethylamine (all components ca. 5 mM), but significant 
destabilization of complex 2C was observed even in the presence of small excesses of 
the Lewis base (Figure S15b). 
Using the stronger Lewis base in the presence of both coupling partners, a 
binary switching response could be achieved (Figure 4 and Table S4) between 
equilibrium compositions favouring almost exclusively salicylate complex 2C (< 5:95 
2A:2C at [DIPEA] = 4.8 mM  1.0 molar equivalents) or catechol complex 2A (> 98:2 
2A:2C at [DIPEA] > 90 mM  19 molar equivalents).(27) Furthermore, simply 
neutralizing all but 1 equivalent of the base by addition of HCl returned the system to 
favour complex 2C. The process was entirely reversible; by sequential addition of base 
then acid, the cycle could be repeated at least three times with no significant loss of 
fidelity (Figure 4 and Table S4). 
 
Figure 4. Base-triggered switching of boronate ester selectivity. High fidelity, 
reversible switching between salicylate boronate complex 2C (blue, low base 
concentration) and catechol boronate ester 2A (red, high base concentration) on cyclic 
variation of the concentration of N,N-diisopropylethylamine (DIPEA) free base by 
alternate addition of DIPEA then HCl. Grey bars: mole fraction of uncomplexed 
boronic acid. Initial concentrations: [2]0 = 4.75 mM  [A]0  [C]0; molar equivalent 
values of free base are estimated volumetrically as protonated and free base forms are in 
fast exchange on the NMR timescale. Concentrations of each species are reported in 
Table S4. 
Conclusions 
Salicylic acids and salicylamides extend the suite of reversible covalent coupling 
partners for boronic acids in nonaqueous solvents. Compared to commonly exploited 
1,2-diphenols, these non-diol motifs are oxidatively stable, and synthetically amenable 
to derivatization. The corresponding boronate ester complexes span a wide range of 
stabilities – tuneable according to the concentration and nature of Lewis base present – 
and exhibit maximum formation constants that can be orders of magnitude higher than 
those achievable with either aromatic or aliphatic diols. 
The factors affecting reversible covalent reactions of boronic acids in 
nonaqueous solvents follow similar principles to the same processes in aqueous 
solution. Although not previously observed in nonaqueous systems, there is an optimum 
base concentration for maximising boronate ester stability, which becomes practically 
relevant for strongly acidic coupling partners such as salicylic acids. Boronate 
complexes with less acidic coupling partners, such as salicylamides, exhibit weaker 
overall formation constants, but maintain their maximum stabilities across a wide range 
of base concentrations. Boronate ester stability can also be manipulated by changing the 
electronic character of the boronic acid and, as is the case in water, the effect on the 
observed ester formation constant is a complex function of the components involved 
and reaction conditions. 
Understanding all these effects is crucial to the application of boronate ester 
dynamic covalent reactivity to create sophisticated functional systems. As a simple 
example, we have achieved repetitive high fidelity reversible switching between two 
boronate ester complexes formed from one boronic acid and two coupling partners, 
triggered only by the concentration of a Lewis base. Being able to rationally exploit 
such behaviours will ultimately allow boronate ester dynamic covalent reactivity to be 
extended far beyond the traditional domains of saccharide sensing and triggered-release 
in aqueous environments, or as a reluctantly reversible linker for the construction of 
cages and framework structures. 
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Scheme 1. Molecular structures of model electron rich (1) and electron poor (2) 
phenylboronic acids; catechol (A, B), salicylic acid (C) and salicylamide (D) coupling 
partners. See Chart S1 for the structures of all boronate ester complexes studied. 
Scheme 2. (a) Simplified general scheme of coupled equilibria describing the 
interactions between a generic boronic acid (Ba) and a ‘non-acidic’ coupling partner P 
(i.e. Ka(P) << Ka(Ba)), in the presence of a generic Lewis base (Lb). (b) Expanded 
scheme of coupled equilibria describing the interactions between a generic boronic acid 
(Ba) and an ‘acidic’ coupling partner P (i.e. Ka(P) >> Ka(Ba)), in the presence of a 
generic Lewis base (Lb). As the acid–base equilibria are all in fast exchange on the 
NMR timescale, apparent association constants observed experimentally correspond to 
the total concentrations of complexed and uncomplexed species: Kapp = [BaP]total / 
([Ba]total[P]total). 
Figure 1. Characterization of boronate ester formation with catechol A in response to 
addition of N-methylmorpholine (NMM) by 19F{1H} NMR (CD3OD, 470.1 MHz, 298 
K). (a) Spectra (top to bottom) of: A + 500 mM NMM; A + 1 (no NMM); A + 1 + 500 
mM NMM. (b) Spectra (top to bottom) of: A + 500 mM NMM; 2 + 500 mM NMM; A 
+ 2 (no NMM); A + 2 + 500 mM NMM. Open symbols: uncomplexed components; 
filled/patterned symbols: boronate ester species. (c) Variation of mole fraction of 
boronate ester with increasing concentration of NMM for 1A (half-filled circles) and 2A 
(filled circles). Initial concentrations: [A]0  [1]0 or [2]0  5 mM. See Figures S1 and S4 
for NMR spectra showing a wider chemical shift range for [NMM] = 5, 50, 500 mM; 
see Figures S13a and S14a for full NMM titration data. 
Figure 2. Response of salicylic acid (C) and salicylamide (D) coupling partners to 
concentration of Lewis base. (a, b) Chemical shift change as a function of concentration 
of N-methylmorpholine (NMM) for (a) C and (b) D. (c) Variation of mole fraction of 
boronate ester with increasing concentration of NMM for 1C (half-filled blue circles) 
and 2C (filled blue circles). (d) Variation of mole fraction of boronate ester with 
increasing concentration of NMM for 1D (half-filled green circles) and 2D (filled green 
circles). Initial concentrations of all boronic acids and coupling partners ca. 5 mM. See 
Figures S2, S3, S6, S7 for representative NMR spectra, and Figures S13, S14 for full 
NMM titration data. 
Figure 3. Apparent formation constants (Kapp) for boronate ester complexes 1A, 1C, 
1D, 2A, 2B, 2C, 2D, measured in CD3OD with varying concentration of N-
methylmorpholine (NMM) and initial concentrations of all boronic acids and coupling 
partners ca. 5 mM. Values expressed as mean  1 standard deviation of three 
independent replicates. For corresponding NMR spectra, see Figures S1–S7. (*) 
Estimated minimum value for 2C at 5 mM NMM (Kapp > 2.2  106 M–1). (†) Value for 
2C at 50 mM NMM determined by a competition experiment. See Supporting 
Information for details. 
Figure 4. Base-triggered switching of boronate ester selectivity. High fidelity, 
reversible switching between salicylate boronate complex 2C (blue, low base 
concentration) and catechol boronate ester 2A (red, high base concentration) on cyclic 
variation of the concentration of N,N-diisopropylethylamine (DIPEA) free base by 
alternate addition of DIPEA then HCl. Grey bars: mole fraction of uncomplexed 
boronic acid. Initial concentrations: [2]0 = 4.75 mM  [A]0  [C]0; molar equivalent 
values of free base are estimated volumetrically as protonated and free base forms are in 
fast exchange on the NMR timescale. Concentrations of each species are reported in 
Table S4. 
 
